EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Isocitrate dehydrogenase (IDH) as target for anticancer therapy in brain and gastrointestinal cancers

Virginia Agnetti, Alessandro Acunzo, Giulia Airò, Alessandro Lazzarin, Eleonora Lai, Maria Michiara, Serafina Martella, Laura Demurtas, Mario Scartozzi, Cinzia Solinas, Chiara Tommasi

Discover Medicine · 10.08.2026 · 3 (1)

DOI: 10.1007/s44337-026-00669-7 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Discover Medicine, online erschienen am 10.08.2026. Verfasst von Virginia Agnetti und 10 weiteren Autor:innen. Die Arbeit nennt 194 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Agnetti, V., Acunzo, A., Airò, G., Lazzarin, A., Lai, E., Michiara, M., Martella, S., Demurtas, L., Scartozzi, M., Solinas, C., & Tommasi, C. (2026). Isocitrate dehydrogenase (IDH) as target for anticancer therapy in brain and gastrointestinal cancers. Discover Medicine, 3(1). https://doi.org/10.1007/s44337-026-00669-7

Vancouver

Agnetti V, Acunzo A, Airò G, Lazzarin A, Lai E, Michiara M, et al. Isocitrate dehydrogenase (IDH) as target for anticancer therapy in brain and gastrointestinal cancers. Discover Medicine. 2026;3(1). doi:10.1007/s44337-026-00669-7

BibTeX
@article{Agnetti2026,
  author = {Agnetti, Virginia and Acunzo, Alessandro and Airò, Giulia and Lazzarin, Alessandro and Lai, Eleonora and Michiara, Maria and Martella, Serafina and Demurtas, Laura and Scartozzi, Mario and Solinas, Cinzia and Tommasi, Chiara},
  title = {Isocitrate dehydrogenase (IDH) as target for anticancer therapy in brain and gastrointestinal cancers},
  journal = {Discover Medicine},
  year = {2026},
  volume = {3},
  number = {1},
  doi = {10.1007/s44337-026-00669-7}
}
Kostenlos starten →